Decision Support for Sinusitis

(CRS-AID Trial)

SW
KH
Overseen ByKevin Hur, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Southern California
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new bilingual web app designed to help people with chronic rhinosinusitis (CRS) make informed treatment decisions. CRS can severely affect daily life, and while surgery is an option when other treatments fail, many patients hesitate to undergo it. Participants will be divided into two groups: one will receive usual information about CRS, and the other will use the new decision-support tool (Patient Centered CRS Treatment Decision Support) alongside standard care. The trial aims to determine if the tool improves decision-making, patient knowledge, and trust in healthcare providers. Ideal candidates for this trial have CRS, haven't found relief with current treatments, are considering sinus surgery, and can access the internet. As an unphased trial, this study offers an opportunity to contribute to research that could enhance treatment decision-making for CRS patients.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It focuses on decision support for sinus surgery, so it's best to ask the study team for guidance.

What prior data suggests that this clinical decision support tool is safe for patients with chronic rhinosinusitis?

Research shows that the patient-centered clinical decision support (PC CDS) tool for chronic rhinosinusitis (CRS) helps patients make informed treatment choices. As a web application, it provides information and supports decision-making without the typical safety concerns of medications or surgeries, such as side effects or adverse reactions.

Previous studies have shown that similar tools can enhance patients' understanding of their condition and increase their involvement in healthcare decisions. Educational tools like this one have no known risks.

The PC CDS tool supports shared decision-making between patients and healthcare providers, fostering trust and satisfaction with care, which is crucial for successful treatment.12345

Why are researchers excited about this trial?

Researchers are excited about the patient-centered clinical decision support (PC CDS) tool for chronic rhinosinusitis (CRS) because it offers a personalized approach to treatment. Unlike the standard care, which typically involves generic informational handouts, this tool helps tailor treatment decisions based on individual patient needs and preferences. By empowering patients to actively participate in their treatment planning, the PC CDS tool aims to improve satisfaction and outcomes, potentially leading to more effective management of CRS.

What evidence suggests that this decision support tool is effective for chronic rhinosinusitis?

Research has shown that tools designed to help patients make decisions about chronic rhinosinusitis (CRS) can lead to better health outcomes. In this trial, participants in the intervention group will use the patient-centered clinical decision support (PC CDS) tool alongside standard care. These tools assist patients in understanding their condition and selecting the best treatment options. Studies have found that when patients participate in decision-making about their care, they feel more satisfied and trust their healthcare providers more. Patient feedback is crucial in assessing the effectiveness of these tools, as it demonstrates real improvements in symptoms and quality of life. Overall, using a decision-making tool can enhance patients' confidence and satisfaction with their treatment choices for CRS.12367

Who Is on the Research Team?

SW

Shinyi Wu, PhD

Principal Investigator

University of Southern California

Are You a Good Fit for This Trial?

This trial is for adults over 18 with chronic rhinosinusitis (CRS) who haven't improved with standard medical treatments and are candidates for sinus surgery. Participants must be able to consent, speak English or Chinese, have internet access via a smart device, and receive care at specific USC clinics in Los Angeles.

Inclusion Criteria

I am receiving care at a USC otolaryngology clinic in Los Angeles, Glendale, La Cañada, or Arcadia.
I am willing and able to agree to participate in the study.
I have a device with internet access.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Development

Development of the patient-centered clinical decision support (PC CDS) tool

Not specified

Randomized Controlled Trial

Participants are randomized into control and intervention groups to evaluate the PC CDS tool

4 months
Multiple visits for surveys and interviews

Follow-up

Participants are monitored for treatment decisions and outcomes

4 months

What Are the Treatments Tested in This Trial?

Interventions

  • Patient Centered CRS Treatment Decision Support

Trial Overview

The study tests a bilingual web app designed to help CRS patients make treatment decisions. It includes educational resources, patient narratives aided by AI, and tools for better doctor-patient communication. The trial compares the app's effectiveness against standard informational handouts in improving decision-making.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Intervention GroupExperimental Treatment1 Intervention
Group II: Control GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Southern California

Lead Sponsor

Trials
956
Recruited
1,609,000+

Citations

Patient-Centered Outcomes in Chronic Rhinosinusitis Trials

Results specify several symptom and impact outcomes, that if improved, would reflect treatment benefit for patients living with CRSwNP, CRSsNP, and/or AFRS.

Treatment Decision-Making Among Patients With Chronic ...

This research aims to develop and pilot-test a patient-centered clinical decision support (PC CDS) web application specifically for patients ...

3.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/26852743/

The Role of the Baseline SNOT-22 in Predicting Outcomes for ...

The majority of participants electing medical therapy failed to improve 1 MCID (57%) with a mean relative score improvement of 16%. Overall, 37% of patients ...

Patient-Reported Outcome Measures in Rhinitis and ...

Patient-reported outcome measures (PROMs) are valuable in the assessment and management of rhinitis and chronic rhinosinusitis (CRS).

PROMs for Adult Chronic Rhinosinusitis: Systematic Review

The objective of this systematic review was to identify and assess the quality of PROMs being used for adults with CRS.

Patient-centered decision making in the treatment ...

Data from this study show that CRS-specific QOL is the main driver of patient-focused clinical decision-making; whereas, the severity of CT scores, endoscopy ...

Assessment of chronic rhinosinusitis with nasal polyps ...

Chronic rhinosinusitis (CRS) is a heterogeneous disorder with a wide range of validated subjective and objective assessment tools to assess ...